-       Report 
- January 2025
-  143 Pages 
- Global 
   From       €2674EUR$2,990USD£2,353GBP 
            -       Report 
- October 2025
-  190 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- August 2024
- Global 
   From       €4292EUR$4,799USD£3,776GBP 
                  The Proteogenomic market is a subset of the Proteomics market, which focuses on the study of proteins and their functions. Proteogenomics combines proteomics with genomics to provide a more comprehensive understanding of the proteins in a given organism. This approach is used to identify and characterize proteins, as well as to study their interactions with other molecules. Proteogenomics can also be used to study the effects of genetic mutations on protein expression and function.
The    Proteogenomic market is expected to grow in the coming years due to the increasing demand for more accurate and comprehensive data on proteins. This data can be used to develop new treatments and therapies for various diseases.
Some companies in the Proteogenomic market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, and PerkinElmer. Show Less   Read more